|
Jun 24, 2022
|
AC Immune Holds Annual General Meeting of Shareholders
|
|
|
Jun 16, 2022
|
AC Immune Provides Update on Alzheimer’s Prevention Initiative Study Evaluating Crenezumab in Autosomal Dominant Alzheimer’s Disease
|
|
|
May 31, 2022
|
AC Immune to Present at the 2022 Jefferies Healthcare Conference
|
|
|
May 17, 2022
|
AC Immune CEO Andrea Pfeifer Receives Aenne Burda Award
|
|
|
May 09, 2022
|
AC Immune’s Anti-Abeta Vaccine Results from Phase 1b Study in Down Syndrome Published in JAMA Neurology
|
|
|
Apr 28, 2022
|
AC Immune Reports First Quarter 2022 Financial Results and Provides Corporate Update
|
|
|
Apr 27, 2022
|
AC Immune to Present at the B. Riley Annual Neuro & Ophthalmology Virtual Investor Conference
|
|
|
Apr 08, 2022
|
AC Immune Reports Changes to Senior Management
|
|
|
Mar 30, 2022
|
AC Immune KOL Webinar on First Clinical Proof of Concept for Alpha-synuclein Diagnostic Shows Breakthrough Potential for Neurodegenerative diseases
|
|
|
Mar 22, 2022
|
AC Immune Reports Full Year 2021 Financial Results and Provides Corporate Update
|
|